MedPath
FDA Approval

Valsartan and Hydrochlorothiazide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 16, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Valsartan(320 mg in 1 1)
Hydrochlorothiazide(25 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

NuCare Pharmaceuticals,Inc.

NuCare Pharmaceuticals,Inc.

010632300

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Valsartan and Hydrochlorothiazide

Product Details

NDC Product Code
68071-4376
Application Number
ANDA201662
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
February 16, 2021
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CROSPOVIDONEInactive
Code: 68401960MKClass: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
ValsartanActive
Code: 80M03YXJ7IClass: ACTIBQuantity: 320 mg in 1 1
Code: 0J48LPH2THClass: ACTIBQuantity: 25 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath